Manfred Scholz

Dr. Scholz was CEO at Prolias LLC, President/COO at Stem Cell Preservation Technologies, VP Business Development at IQuum, Sr Director Business Development at Large Scale Biology Corporation, Sr Consultant at Boston Biomedical Consultants, and held various system development and global marketing positions at Dade Behring (now Siemens). Earlier in his career, he held research positions at Massachusetts General Hospital, Harvard Medical School and Max Planck Institute for Biophysics. He researched and published in the fields of oncology, infectious diseases and in vivo imaging technologies. He received his Ph.D. in physics from Johann Wolfgang Goethe-University, Frankfurt, Germany and his M.B.A. from Babson College, Wellesley, Massachusetts.

In the past, percussion of the abdomen, taking temperature, or tasting sugar in urine were considered diagnostic standard of care methodologies. Today, invitro diagnostics (IVD) provide additional objective biomarkers that diagnose cancer, infections, heart attacks and many other health conditions.